Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INITIALISE: Imatinib and Fluid in LPS Sepsis Model
NCT06626984Phase 2Not yet recruiting
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Dec 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of imatinib in sepsis (4 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Biomarkers of vascular and glycocalyx injury at 8 hours. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT06626984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06626984.